Abstract
e17570 Background: NCI/NCCN designated CC offer cancer pts state-of-the-art treatment, access to expertise and clinical trials. Their impact on pt outcomes has not been systematically evaluated, especially for racial minorities where disparities in healthcare access and outcomes are known to exist. We undertook such an analysis for MM pts. Methods: Adult pts with MM diagnosed 1973-2011 were identified from Surveillance Epidemiology and End Results (SEER) registry and stratified by county of residence at time of MM diagnosis (Dx) and year (yr) of CC designation (those after 2011 were excluded). Pts and NCI/NCCN CC in counties not contributing to SEER registry were excluded from analysis. Influence of NCI/NCCN CC access (noted as 0, 1 or ≥2 per county), race and yr of Dx on OS was evaluated by Cox regression model. Results: Counties with 0, 1 or >2 NCI CC (4, 13 and 2, respectively) and with 0 or 1 NCCN CC (9 and 5, respectively) were identified with total of 71,364 pts (male: 38,361; female: 33,003). Pts b...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
